Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cashflow Statement

INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax₹193 Cr₹237 Cr₹132 Cr₹29 Cr₹-9.31 Cr
Adjustment ₹121 Cr₹87 Cr₹110 Cr₹100 Cr₹89 Cr
Changes In working Capital ₹-73 Cr₹-109 Cr₹-140 Cr₹-1.49 Cr₹56 Cr
Cash Flow after changes in Working Capital ₹240 Cr₹215 Cr₹102 Cr₹127 Cr₹136 Cr
Cash Flow from Operating Activities ₹179 Cr₹174 Cr₹82 Cr₹123 Cr₹132 Cr
Cash Flow from Investing Activities ₹-208 Cr₹-121 Cr₹-67 Cr₹-56 Cr₹-104 Cr
Cash Flow from Financing Activities ₹23 Cr₹-44 Cr₹-30 Cr₹-64 Cr₹-16 Cr
Net Cash Inflow / Outflow ₹-6.53 Cr₹8.05 Cr₹-14 Cr₹2.97 Cr₹12 Cr
Opening Cash & Cash Equivalents ₹17 Cr₹9.42 Cr₹24 Cr₹21 Cr₹8.58 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹11 Cr₹17 Cr₹9.42 Cr₹24 Cr₹21 Cr

Compare Cashflow Statement of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹3,050.9 Cr -0.1% -11.7% 1.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,311.0 Cr 3% 2.3% 68.2% Stock Analytics
CIPLA ₹108,623.0 Cr 2.5% 0.4% 71.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,134.3 Cr -0.2% -4.9% 40.3% Stock Analytics
DIVIS LABORATORIES ₹97,408.4 Cr -1.6% -7% 23.8% Stock Analytics
ZYDUS LIFESCIENCES ₹92,794.9 Cr 5% 10.4% 109.1% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-0.1%

-11.7%

1.9%

SENSEX

-2.6%

-0%

21%


You may also like the below Video Courses